FOXO3 and hepatocellular carcinoma: Interestingly, FOXO3a activation was observed to be downregulated in doxorubicin-treated HCC cells in the current study, and salinomycin was found to enhance cytotoxicity of doxorubicin in HCC cells by preventing the EMT process via the activation of FOXO3a.